packageGilteritinib

gilteritinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Gilteritinib is a protein kinase inhibitor used to treat acute myeloid leukemia. It is an approved medicine, authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q27077802 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:gilteritinib
ATC codes:L01EX13
DrugBank:DB12141
PubChem CID:49803313
ChEBI:145372
Wikidata:Q27077802
formula:C29H44N8O3
molar mass:552.724 g/mol (PubChem CID 49803313)
logP:3.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown